Characterization of Focal Liver Lesions with Contrast-Enhanced Ultrasound

Ultrasound in Medicine and Biology

Volumn 36, Issue 4, 2010, Pages 531-550

  Piscaglia, Fabio ^a   Lencioni, Riccardo ^b   Sagrini, Elisabetta ^a   Pina, Clotilde Dalla ^b   Cioni, Dania ^b   Vidili, Giampaolo ^a   Bolondi, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Liver neoplasms; Microbubbles; Ultrasonography

Indexed keywords

BASIC PRINCIPLES; CONTRAST AGENT; CONTRAST ENHANCED ULTRASOUND; CONTRAST-ENHANCED; FOCAL LIVER LESIONS; HEPATIC LESIONS; LIVER NEOPLASMS; LIVER TUMORS; MICRO-BUBBLE; MICROBUBBLES; MILAN , ITALY; SECOND GENERATION;

IONIZING RADIATION; TUMORS; ULTRASONIC IMAGING; ULTRASONICS; ULTRASONOGRAPHY;

LIVER;

SONOVUE;

B SCAN; BENIGN TUMOR; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FATTY LIVER; HUMAN; IMAGE ANALYSIS; IONIZING RADIATION; LIVER ABSCESS; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HEMANGIOMA; LIVER TUMOR; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MICROBUBBLE; NODULAR HYPERPLASIA; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; ULTRASOUND;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MICROBUBBLES; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 77950301866     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.01.004     Document Type: Review

References (58)

1. Albrecht T., Hohmann J., Oldenburg A., Skrok J., Wolf K.J. Detection and characterization of liver metastases. Eur Radiol 2004, 14:25-33.
2. Bacq Y., Jacquemin E., Balabaud C., Jeannot E., Scotto B., Branchereau S., Laurent C., Bourlier P., Pariente D., de Muret A., Fabre M., Bioulac-Sage P., Zucman-Rossi J. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 2003, 125:1470-1475.
3. Bartolozzi C., Lencioni R., Paolicchi A., Moretti M., Armillotta N., Pinto F. Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: Comparison of power Doppler imaging and conventional color Doppler sonography. Eur Radiol 1997, 7:1410-1415.
4. Bertolotto M., Dalla Palma L., Quaia E., Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: Preliminary results. Eur Radiol 2000, 10:1369-1376.
5. Bioulac-Sage P., Rebouissou S., Thomas C., Blanc J.F., Saric J., Sa Cunha A., Rullier A., Cubel G., Couchy G., Imbeaud S., Balabaud C., Zucman-Rossi J. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007, 46:740-748.
6. Blomley M.J., Cooke J.C., Unger E.C., Monaghan M.J., Cosgrove D.O. Microbubble contrast agents: A new era in ultrasound. BMJ 2001, 322:1222-1225.
7. Bolondi L., Sofia S., Siringo S., Gaiani S., Casali A., Zironi G., Piscaglia F., Gramantieri L., Zanetti M., Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis. Gut 2001, 48:251-259.
8. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003, 39:1076-1084.
9. Bolondi L., Gaiani S., Celli N., Golfieri R., Grigioni W.F., Leoni S., Venturi A.M., Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
10. Bolondi L., Correas J.M., Lencioni R., Weskott H.P., Piscaglia F. New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 2007, 39:187-195.
11. Borzio M., Borzio F., Croce A., Sala M., Salmi A., Leandro G., Bruno S., Roncalli M. Ultrasonography-detected macroregenerative nodules in cirrhosis: A prospective study. Gastroenterology 1997, 112:1617-1623.
12. Bosch F.X., Ribes J. Epidemiology of liver cancer in Europe. Can J Gastroenterol 2000, 14:621-630.
13. Brannigan M., Burns P.N., Wilson S.R. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004, 24:921-935.
14. Bruix J., Sherman M., Llovet J., Beaugrand M., Lencioni R., Burroughs A., Christensen E., Pagliaro L., Colombo M., Rodes J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001, 35:421-430. EASL Panel of Experts on HCC.
15. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
16. Burns P.N., Wilson S.R. Microbubble contrast for radiological imaging: 1. Principles. Ultrasound Q 2006, 22:5-13.
17. Caremani M., Lapini L., Caremani D., Occhini U. Sonographic diagnosis of hydatidosis: The sign of the cyst wall. Eur J Ultrasound 2003, 16:217-223.
18. Catalano O., Sandomenico F., Raso M.M., Siani A. Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. AJR Am J Roentgenol 2004, 182:447-450.
19. Caturelli E., Bartolucci F., Biasini E., Vigliotti M.L., Andriulli A., Siena D.A., Attino V., Bisceglia M. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 2002, 97:397-405.
20. Claudon M., Cosgrove D., Albrecht T., Bolondi L., Bosio M., Calliada F., Correas J.M., Darge K., Dietrich C., D'Onofrio M., Evans D.H., Filice C., Greiner L., Jager K., Jong N., Leen E., Lencioni R., Lindsell D., Martegani A., Meairs S., Nolsoe C., Piscaglia F., Ricci P., Seidel G., Skjoldbye B., Solbiati L., Thorelius L., Tranquart F., Weskott H.P., Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 2008, 29:28-44.
21. Colombo M., de Franchis R., Del Ninno E., Sangiovanni A., De Fazio C., Tommasini M., Donato M.F., Piva A., Di Carlo V., Dioguardi N. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991, 325:675-680.
22. Dietrich C.F., Schuessler G., Trojan J., Fellbaum C., Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005, 78:704-707.
23. Dietrich C.F., Mertens J.C., Braden B., Schuessler G., Ott M., Ignee A. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007, 45:1139-1145.
24. Forner A., Vilana R., Ayuso C., Bianchi L., Sole M., Ayuso J.R., Boix L., Sala M., Varela M., Llovet J.M., Bru C., Bruix J. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008, 47:97-104.
25. Fukukura Y., Nakashima O., Kusaba A., Kage M., Kojiro M. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol 1998, 29:470-475.
26. Furuya K., Nakamura M., Yamamoto Y., Togei K., Otsuka H. Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 1988, 61:99-105.
27. Gaiani S., Piscaglia F., Serra C., Bolondi L. Hemodynamics in focal nodular hyperplasia. J Hepatol 1999, 31:576.
28. Gaiani S., Casali A., Serra C., Piscaglia F., Gramantieri L., Volpe L., Siringo S., Bolondi L. Assessment of vascular patterns of small liver mass lesions: Value and limitation of the different Doppler ultrasound modalities. Am J Gastroenterol 2000, 95:3537-3546.
29. Gaiani S., Volpe L., Piscaglia F., Bolondi L. Vascularity of liver tumours and recent advances in Doppler ultrasound. J Hepatol 2001, 34:474-482.
30. Gaiani S., Celli N., Piscaglia F., Cecilioni L., Losinno F., Giangregorio F., Mancini M., Pini P., Fornari F., Bolondi L. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004, 41:421-426.
31. Giorgio A., De Stefano G., Coppola C., Ferraioli G., Esposito V., Di Sarno A., Giorgio V., De Stefano M., Sangiovanni V., Liorre G., Del Viscovo L. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: Comparison with contrast-enhanced ultrafast magnetic resonance imaging. Anticancer Res 2007, 27:4263-4269.
32. Jang H.J., Kim T.K., Wilson S.R. Imaging of malignant liver masses: Characterization and detection. Ultrasound Q 2006, 22:19-29.
33. Kim J.H., Kim T.K., Kim B.S., Eun H.W., Kim P.N., Lee M.G., Ha H.K. Enhancement of hepatic hemangiomas with levovist on coded harmonic angiographic ultrasonography. J Ultrasound Med 2002, 21:141-148.
34. Kim K.W., Choi B.I., Park S.H., Kim A.Y., Koh Y.H., Lee H.J., Han J.K. Pyogenic hepatic abscesses: Distinctive features from hypovascular hepatic malignancies on contrast-enhanced ultrasound with SH U 508A; early experience. Ultrasound Med Biol 2004, 30:725-733.
35. Kim S.R., Ando K., Mita K., Fuki S., Ikawa H., Kanbara Y., Imoto S., Matsuoka T., Hayashi Y., Kudo M. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm. Oncology 2007, 72:158-166.
36. Kim T.K., Jang H.J., Burns P.N., Murphy-Lavallee J., Wilson S.R. Focal nodular hyperplasia and hepatic adenoma: Differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 2008, 190:58-66.
37. Kojiro M., Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005, 25:133-142.
38. Leen E. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 2001, 11:27-34.
39. Lencioni R., Cioni D., Bartolozzi C. Tissue harmonic and contrast-specific imaging: Back to gray-scale in ultrasound. Eur Radiol 2002, 12:151-165.
40. Lencioni R., Piscaglia F., Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 2008, 48:848-857.
41. Lerut J.P., Ciccarelli O., Sempoux C., Danse E., deFlandre J., Horsmans Y., Sokal E., Otte J.B. Glycogenosis storage type I diseases and evolutive adenomatosis: An indication for liver transplantation. Transpl Int 2003, 16:879-884.
42. Morel D.R., Schwieger I., Hohn L., Terrettaz J., Llull J.B., Cornioley Y.A., Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000, 35:80-85.
43. Nicolau C., Bru C. Focal liver lesions: Evaluation with contrast-enhanced ultrasonography. Abdom Imaging 2004, 29:348-359.
44. Nicolau C., Catala V., Vilana R., Gilabert R., Bianchi L., Sole M., Pages M., Bru C. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: Correlation with cellular differentiation. Eur Radiol 2004, 14:1092-1099.
45. Piscaglia F., Leoni S., Venturi A., Bolondi L. Clinico-Pathological Classification. Focal liver lesions 2005, 75-84. Springer, Berlin. R. Lencioni, D. Cioni, C. Bartolozzi (Eds.).
46. Piscaglia F., Bolondi L. The safety of Sonovue in abdominal applications: Retrospective analysis of 23,188 investigations. Ultrasound Med Biol 2006, 32:1369-1375.
47. Quaia E., Calliada F., Bertolotto M., Rossi S., Garioni L., Rosa L., Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulphur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 2004, 232:420-430.
48. Reznik Y., Dao T., Coutant R., Chiche L., Jeannot E., Clauin S., Rousselot P., Fabre M., Oberti F., Fatome A., Zucman-Rossi J., Bellanne-Chantelot C. Hepatocyte nuclear factor-1 alpha gene inactivation: Cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 2004, 89:1476-1480.
49. Rickes S., Ocran K.W., Gerstenhauer G., Neye H., Wermke W. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound. Dig Liv Dis 2004, 22:81-86.
50. Solbiati L, Cova L, Kirn V, Tonolini M. Contrast-enhanced sonography is highly reliable and potentially cost-effective for characterization focal liver lesions initially detected by unenhanced sonography. RSNA Chicago 2004; Nov 28-Dec 3: abstracts, p. 426.
51. Strobel D., Kleinecke C., Hansler J., Frieser M., Handl T., Hahn E.G., Bernatik T. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas-correlation with histological differentiation. Ultraschall Med 2005, 26:270-276.
52. Tanaka S., Ioka T., Oshikawa O., Hamada Y., Yoshioka F. Dynamic sonography of hepatic tumors. AJR Am J Roentgenol 2001, 177:799-805.
53. Torbenson M., Lee J.H., Choti M., Gage W., Abraham S.C., Montgomery E., Boitnott J., Wu T.T. Hepatic adenomas: Analysis of sex steroid receptor status and the Wnt signalling pathway. Mod Pathol 2002, 15:189-196.
54. Venturi A., Piscaglia F., Silvagni E., Righini R., Fabbrizio B., Cescon M., Bolondi L. Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis. Ultraschall Med 2007, 28:75-78.
55. Vilgrain V., Boulos L., Vullierme M.P., Denys A., Terris B., Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 2000, 20:379-397.
56. Von Herbay A., Vogt C., Haussinger D. Differentiation between benign and malignant hepatic lesions: Utility of color-stimulated acoustic emission with the microbubble contrast agent Levovist. J Ultrasound Med 2004, 23:207-215.
57. Wen Y.L., Kudo M., Zheng R.Q., Ding H., Zhou P., Minami Y., Chung H., Kitano M., Kawasaki T., Maekawa K. Characterization of hepatic tumors: Value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004, 182:1019-1026.
58. Zucman-Rossi J., Jeannot E., Nhieu J.T., Scoazec J.Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E.S., Laurent-Puig P., Balabaud C., Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC. Hepatology 2006, 43:515-524.